InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,225.46
(
0.05%
)
US TECH 100
17,717.20
(
0.20%
)
Dow Jones
39,553.16
(
0.10%
)
Brent Oil
83.29
(
1.09%
)
Bitcoin
62,765.48
(
2.14%
)
Post# of 675
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

cfoofme

Send PM Follow Ignore
Followers 61
Posts 6981
Boards Moderated 0
Alias Born 10/03/2004

cfoofme

Re: None

Wednesday, 08/12/2009 12:40:54 PM

Wednesday, August 12, 2009 12:40:54 PM

Post# of 675
Post from another board:

By: sixersadvantcom
11 Aug 2009, 08:55 PM EDT
Rating: Rate this post: Msg. 266 of 267

Jump to msg. #
Second Quarter Results.

1.Gross Margin 56.6%, Great.

2.Operating Expenses Down 31%, Great.

3.Revenue $3.47 million, Room for improvement but the increase of backlog to $4.3 million is the spoonful of sugar which helps the medicine go down.

4.Positive EBITDA good but looking for positive earnings.

5.Overall very good especially considering the economic climate.

bob


Send stock manipulators to: enforcement@sec.gov-and to jail.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up